133 related articles for article (PubMed ID: 7983000)
1. Distinct roles of the intracellular domains of transforming growth factor-beta type I and type II receptors in signal transduction.
Okadome T; Yamashita H; Franzén P; Morén A; Heldin CH; Miyazono K
J Biol Chem; 1994 Dec; 269(49):30753-6. PubMed ID: 7983000
[TBL] [Abstract][Full Text] [Related]
2. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta.
Saitoh M; Nishitoh H; Amagasa T; Miyazono K; Takagi M; Ichijo H
J Biol Chem; 1996 Feb; 271(5):2769-75. PubMed ID: 8576253
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
[TBL] [Abstract][Full Text] [Related]
4. Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes.
Vivien D; Attisano L; Wrana JL; Massagué J
J Biol Chem; 1995 Mar; 270(13):7134-41. PubMed ID: 7706250
[TBL] [Abstract][Full Text] [Related]
5. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex.
Cárcamo J; Zentella A; Massagué J
Mol Cell Biol; 1995 Mar; 15(3):1573-81. PubMed ID: 7862150
[TBL] [Abstract][Full Text] [Related]
6. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region.
Wieser R; Attisano L; Wrana JL; Massagué J
Mol Cell Biol; 1993 Dec; 13(12):7239-47. PubMed ID: 8246946
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
[TBL] [Abstract][Full Text] [Related]
8. A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation.
Zhu HJ; Sizeland AM
J Biol Chem; 1999 Apr; 274(17):11773-81. PubMed ID: 10206994
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.
Feng XH; Filvaroff EH; Derynck R
J Biol Chem; 1995 Oct; 270(41):24237-45. PubMed ID: 7592630
[TBL] [Abstract][Full Text] [Related]
10. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta.
Yamashita H; ten Dijke P; Franzén P; Miyazono K; Heldin CH
J Biol Chem; 1994 Aug; 269(31):20172-8. PubMed ID: 8051105
[TBL] [Abstract][Full Text] [Related]
11. Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells.
Doré JJ; Edens M; Garamszegi N; Leof EB
J Biol Chem; 1998 Nov; 273(48):31770-7. PubMed ID: 9822641
[TBL] [Abstract][Full Text] [Related]
12. The GS domain of the transforming growth factor-beta type I receptor is important in signal transduction.
Franzén P; Heldin CH; Miyazono K
Biochem Biophys Res Commun; 1995 Feb; 207(2):682-9. PubMed ID: 7864860
[TBL] [Abstract][Full Text] [Related]
13. Extracellular domain of the transforming growth factor-beta receptor negatively regulates ligand-independent receptor activation.
Zhu HJ; Sizeland AM
J Biol Chem; 1999 Oct; 274(41):29220-7. PubMed ID: 10506179
[TBL] [Abstract][Full Text] [Related]
14. [Functional analysis of transforming growth factor-beta type I receptor].
Saitoh M
Kokubyo Gakkai Zasshi; 1996 Mar; 63(1):42-52. PubMed ID: 8725356
[TBL] [Abstract][Full Text] [Related]
15. [Functional analysis of transforming growth factor-beta type II dominant negative receptor].
Takarada M
Kokubyo Gakkai Zasshi; 1996 Jun; 63(2):375-86. PubMed ID: 8741521
[TBL] [Abstract][Full Text] [Related]
16. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
Mori N; Morishita M; Tsukazaki T; Yamamoto N
Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
[TBL] [Abstract][Full Text] [Related]
17. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors.
Rodriguez C; Chen F; Weinberg RA; Lodish HF
J Biol Chem; 1995 Jul; 270(27):15919-22. PubMed ID: 7608141
[TBL] [Abstract][Full Text] [Related]
18. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
Stockwell BR; Schreiber SL
Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture.
Yamamoto H; Ueno H; Ooshima A; Takeshita A
J Biol Chem; 1996 Jul; 271(27):16253-9. PubMed ID: 8663151
[TBL] [Abstract][Full Text] [Related]
20. Ligand-independent activation of transforming growth factor (TGF) beta signaling pathways by heteromeric cytoplasmic domains of TGF-beta receptors.
Feng XH; Derynck R
J Biol Chem; 1996 May; 271(22):13123-9. PubMed ID: 8662796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
